Molecular characterization of human and mouse fatty acid amide hydrolases - Wikidata - wikimedia - TriplyDB

Molecular characterization of human and mouse fatty acid amide hydrolases

Molecular characterization of human and mouse fatty acid amide hydrolases

http://www.wikidata.org/entity/Q24317261

about

Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase Endocannabinoid signaling in female reproduction A hypothesis about the endogenous analogue of general anesthesia The endocannabinoid system as a target for the treatment of cannabis dependence Evidence against the presence of an anandamide transporter Of mice and (wo)men: factors influencing successful implantation including endocannabinoids Ulcerative colitis induces changes on the expression of the endocannabinoid system in the human colonic tissue X-ray Crystallographic Analysis of α-Ketoheterocycle Inhibitors Bound to a Humanized Variant of Fatty Acid Amide Hydrolase Fluoride-Mediated Capture of a Noncovalent Bound State of a Reversible Covalent Enzyme Inhibitor: X-ray Crystallographic Analysis of an Exceptionally Potent α-Ketoheterocycle Inhibitor of Fatty Acid Amide Hydrolase Reversible Competitive α-Ketoheterocycle Inhibitors of Fatty Acid Amide Hydrolase Containing Additional Conformational Constraints in the Acyl Side Chain: Orally Active, Long-Acting Analgesics Rational Design of Fatty Acid Amide Hydrolase Inhibitors That Act by Covalently Bonding to Two Active Site Residues Cannabinoids, endocannabinoids, and cancer Inhibition of FAAH and activation of PPAR: new approaches to the treatment of cognitive dysfunction and drug addiction Fatty acid amide hydrolase as a potential therapeutic target for the treatment of pain and CNS disorders Enzymatic pathways that regulate endocannabinoid signaling in the nervous system Keys to Lipid Selection in Fatty Acid Amide Hydrolase Catalysis: Structural Flexibility, Gating Residues and Multiple Binding Pockets Evidence for distinct roles in catalysis for residues of the serine-serine-lysine catalytic triad of fatty acid amide hydrolase Deletion of a proline-rich region and a transmembrane domain in fatty acid amide hydrolase.Localisation and function of the endocannabinoid system in the human ovary.Alcohol dehydrogenase-catalyzed in vitro oxidation of anandamide to N-arachidonoyl glycine, a lipid mediator: synthesis of N-acyl glycinals.Genetic loss of Faah compromises male fertility in mice.Lipid droplets are novel sites of N-acylethanolamine inactivation by fatty acid amide hydrolase-2.α-Ketoheterocycle inhibitors of fatty acid amide hydrolase: exploration of conformational constraints in the acyl side chain.Interactions of Cannabinoids With Biochemical Substrates Incorporation of therapeutically modified bacteria into gut microbiota inhibits obesity.Endocannabinoid binding to the cannabinoid receptors: what is known and what remains unknown.The discovery and development of inhibitors of fatty acid amide hydrolase (FAAH).A missense mutation in human fatty acid amide hydrolase associated with problem drug use.Discovery libraries targeting the major enzyme classes: the serine hydrolases.Discovery of MK-4409, a Novel Oxazole FAAH Inhibitor for the Treatment of Inflammatory and Neuropathic Pain.Plant responses to bacterial N-acyl L-homoserine lactones are dependent on enzymatic degradation to L-homoserine Lipid profiling reveals tissue-specific differences for ethanolamide lipids in mice lacking fatty acid amide hydrolase.Functional disassociation of the central and peripheral fatty acid amide signaling systems.Microwave Assisted Synthesis of Sodium Sulfonates Precursors of Sulfonyl Chlorides and Fluorides.Combined inhibition of FAAH and COX produces enhanced anti-allodynic effects in mouse neuropathic and inflammatory pain models.Sulfonyl fluoride inhibitors of fatty acid amide hydrolase.The endocannabinoid system and pain Inhibition of FAAH, TRPV1, and COX2 by NSAID-serotonin conjugates.Anandamide oxidation by wild-type and polymorphically expressed CYP2B6 and CYP2D6.'Entourage' effects of N-acyl ethanolamines at human vanilloid receptors. Comparison of effects upon anandamide-induced vanilloid receptor activation and upon anandamide metabolism

P2860

08fceacdddb1b3302e86e9def1c0ead5dca4294b 16fddbbbd2d69a3cbb3704cbea1e5f350148840f 6a05fcdfa142b07a43d1a56b26356c14cc6158ac a4fc193e09fc668c00ae1fdc17e08f1cd43bef84

P248

Q24555807-4BCB21C5-37C7-4499-88DB-9E9844AD4432 Q24599033-7D0633B3-6628-4D43-83E7-A709B5CD8E9A Q24601737-F504CE7F-3B24-468E-AC0F-517A04BC0E32 Q24648135-2A88682E-880A-4B6B-B634-8EFD29D379A9 Q24683153-834C7FCF-4FAB-4DBE-98CE-AC25A07B0869 Q26992063-24F789C2-92B3-465E-9C6E-A1CA4D86B125 Q27342536-64105E96-9DEF-4CB0-AE3D-C7DD0D7A62AE Q27658264-1D416DF4-D6C0-4087-AA18-D7379054F96F Q27667078-17F9AB68-FB4E-4832-A5BC-23273E98EAD6 Q27667312-C1C71046-6889-4138-9C7F-B61BE8BAA65F Q27677344-A14CB44B-227A-4749-8BDF-5E080417732B Q27694715-F33914E7-2BBF-45A6-90E4-85F893F6C05B Q28283718-2856781A-84F5-4373-AAA9-FEC6213DFDD9 Q28285103-DB696955-BBF1-49D4-BB1D-75DD15CF50B3 Q28390932-8E77EFBE-2FD4-426D-A745-D38E104813D3 Q28548681-DD899716-76E6-4AFC-A79D-748D66FBDB49 Q28570492-8B551296-FAC3-413E-B0F2-F946BCB344C5 Q30175394-846F06C4-A915-4385-A8C6-7031A2B8B785 Q33411754-898FF330-566E-4C9C-9C4B-EF9F5D2904EF Q33560137-96A69A75-80E3-4903-AF86-99247D388AA0 Q33583700-2DF83043-DAE0-47A1-8E60-0781599CF7DC Q33594073-EA8212B9-5DE7-4758-93AD-BE1C27AAEC06 Q33644120-08654AC3-1103-489A-A70C-AFA06FADFAC3 Q33758351-24A54E04-2FE9-4B27-A357-116A64246859 Q33944259-119845B9-CC88-4259-A79F-5D091E58A1B5 Q33997873-82EF67E2-A4DE-40D3-89EF-6608A9AB1634 Q34027721-2B42E447-D0FE-4A7F-90C2-5924002632AE Q34032872-71226CC1-2750-4153-B17E-97EB750D8593 Q34036280-E3719841-26E3-4D47-9718-D6CFC4F00FA0 Q34041284-FC764E41-4D7E-403B-A91C-6FCD22411FBC Q34061224-453FE697-4C6E-4C3B-B1C1-3C6AB91A1798 Q34150144-C80C4A64-00BB-4C83-8751-D9E8DC7905AF Q34332678-41BDAE50-6751-4B43-BF3C-426BBCF082A0 Q34363783-78AA17F3-4B48-4049-B815-A944FEBD0AF6 Q34390806-802404AB-018C-4AFE-B955-8F43FA28E922 Q34452685-7C4B878D-2017-443E-AC2C-EA8B16B06943 Q34612917-17ACD3C6-9A94-4B71-BF15-0E7CAD7373A0 Q34644485-6C35500A-69F2-44E6-A2F9-11FBB8E16E8C Q34856974-44DA8819-1CC8-471A-BCC9-8EEDDEBBD1ED Q35044394-AAAADA66-0D4B-4E4B-9626-80F9503E56F8

P2860

Molecular characterization of human and mouse fatty acid amide hydrolases

http://www.wikidata.org/entity/Q24317261

description

1997 nî lūn-bûn

@nan

1997 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

1997 թվականի մարտին հրատարակված գիտական հոդված

@hy

1997年の論文

@ja

1997年論文

@yue

1997年論文

@zh-hant

1997年論文

@zh-hk

1997年論文

@zh-mo

1997年論文

@zh-tw

1997年论文

@wuu

name

Molecular characterization of human and mouse fatty acid amide hydrolases

@ast

Molecular characterization of human and mouse fatty acid amide hydrolases

@en

Molecular characterization of human and mouse fatty acid amide hydrolases

@en-gb

Molecular characterization of human and mouse fatty acid amide hydrolases

@nl

type

label

Molecular characterization of human and mouse fatty acid amide hydrolases

@ast

Molecular characterization of human and mouse fatty acid amide hydrolases

@en

Molecular characterization of human and mouse fatty acid amide hydrolases

@en-gb

Molecular characterization of human and mouse fatty acid amide hydrolases

@nl

prefLabel

Molecular characterization of human and mouse fatty acid amide hydrolases

@ast

Molecular characterization of human and mouse fatty acid amide hydrolases

@en

Molecular characterization of human and mouse fatty acid amide hydrolases

@en-gb

Molecular characterization of human and mouse fatty acid amide hydrolases

@nl

P1433

Q24317261-DDA85581-A269-4BCC-811E-9730E67CABDB

P1476

Q24317261-FA059036-EF9B-40B0-96E9-96F528678D28

P2093

Q24317261-05A8CA63-1C64-4AB2-8719-0CCF5DF898D9

Q24317261-D3A65117-7987-4FFE-9857-8F7E78C0FD3A

P2860

Q24317261-0091E9F9-4B55-412C-A556-7583AFB38B8B

Q24317261-0B1C6C30-648B-4B17-9F47-9948D1C8A1A2

Q24317261-15E4EE9D-1D4E-481E-ABA1-3B5ED5B7196C

Q24317261-1BAC1A1C-E166-41C2-95A5-551D01448799

Q24317261-318101D6-22AA-48EE-9B88-44A4DA45DD5F

Q24317261-60067E02-1AFC-4752-92DB-874B70B706C2

Q24317261-61AEB485-46CD-4423-9577-C76A483CE800

Q24317261-670335FD-3AA4-43AD-B483-8B71CE5C93D5

Q24317261-6736209A-159E-4D8D-A4FF-3A18C3B166BE

Q24317261-7B701447-126B-4601-8058-1437FD94E43E

P304

Q24317261-9E15B88A-B1AC-441D-A307-97E8AC794662

P31

Q24317261-F4D1E882-D501-4094-86E6-34DD053111E5

P356

Q24317261-83FF417F-596E-4B64-80FF-1317A0BE1058

P407

Q24317261-562CE911-37BB-4E28-AB7A-B1BC654C1B30

P433

Q24317261-B4AF1D65-B8B5-4D1E-B89D-8E4FCA343C44

P478

Q24317261-03DDCAA3-7CA9-417F-92CA-36BD7D5FB73C

P577

Q24317261-D03ECEB2-9F0B-4263-BD6E-52D232AD75BE

P5875

Q24317261-DFB27908-AA26-477B-AC22-6E8746ABFF91

P698

Q24317261-CFF6051A-0E1B-4186-BF5D-F602BAC2C09D

P921

Q24317261-808F5242-D944-4A74-A160-F329934623D9

Q24317261-AD662131-254F-46B2-A8A0-E509DA9B0F19

Q24317261-C9905963-7C02-4912-8229-D9CB7CB2F222

P932

Q24317261-93014A31-6D10-48D0-A9E4-9E107296ED48

P356

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Molecular characterization of human and mouse fatty acid amide hydrolases

@en

P2093

B F Cravatt

http://www.w3.org/2001/XMLSchema#string

D K Giang

http://www.w3.org/2001/XMLSchema#string

P2860

The preimplantation mouse embryo is a target for cannabinoid ligand-receptor signaling

Two binding orientations for peptides to the Src SH3 domain: development of a general model for SH3-ligand interactions

Enzymatic synthesis and degradation of anandamide, a cannabinoid receptor agonist

Fatty acid amide biosynthesis: a possible new role for peptidylglycine alpha-amidating enzyme and acyl-coenzyme A: glycine N-acyltransferase

Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides

Chemical characterization of a family of brain lipids that induce sleep

Isolation and structure of a brain constituent that binds to the cannabinoid receptor

Formation and inactivation of endogenous cannabinoid anandamide in central neurons

Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide

The ALIAmide palmitoylethanolamide and cannabinoids, but not anandamide, are protective in a delayed postglutamate paradigm of excitotoxic death in cerebellar granule neurons

P304

2238-42

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.94.6.2238

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

94

http://www.w3.org/2001/XMLSchema#string

P577

1997-03-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

14096504

http://www.w3.org/2001/XMLSchema#string

P698

9122178

http://www.w3.org/2001/XMLSchema#string

P921

fatty acid amide hydrolase activity

Fatty acid amide hydrolase

P932

20071

http://www.w3.org/2001/XMLSchema#string